SpringerLink
Log in

Lamotrigine

  • Chapter
  • First Online:
Antiseizure Medication Interactions

  • 818 Accesses

Abstract

The pharmacokinetic characteristics of lamotrigine are described, and the interaction effects of concomitant antiseizure medications on lamotrigine in terms of its pharmacokinetics and pharmacodynamics are highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Spain)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 96.29
Price includes VAT (Spain)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 124.79
Price includes VAT (Spain)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Moseley BD, Otoul C, Staelens L, Stockis A. Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: pooled analysis of data from randomized clinical trials. Epilepsy Res. 2019;158:106218.

    Article  CAS  Google Scholar 

  2. Gaston TE, Bekib EM, Cutter GR, Liu Y, Szaflarski JP, UAB CBD Program. Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia. 2017;58:1586–92.

    Article  CAS  Google Scholar 

  3. Weintraub D, Buchsbaum R, Resor SR, Hirsch LJ. Effect of antiepileptic drug comedication on lamotrigine clearance. Arch Neurol. 2005;62:1432–6.

    Article  Google Scholar 

  4. Besag FM, Berry DJ, Pool F, Newbery JE, Subel B. Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? Epilepsia. 1998;39:183–7.

    Article  CAS  Google Scholar 

  5. Summary of product characteristics: Cenobamate (XCopri). SK Life Science Inc. Last update Aug 2020.

    Google Scholar 

  6. Armijo JA, Bravo J, Cuadrado A, Herranz JL. Lamotrigine serum concentration-to-dose ratio: influence of age and concomitant antiepileptic drugs and dosage implications. Ther Drug Monit. 1999;21:182–90.

    Article  CAS  Google Scholar 

  7. Almeida L, Nunes T, Sicard E, Rocha JF, Falcao A, Brunet JS, Lefebvre M, Soares-da-Silva P. Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects. Acta Neurol Scand. 2010;121:257–64.

    Article  CAS  Google Scholar 

  8. Colucci R, Glue P, Holt B, Banfield C, Reidenberg P, Meehan JW, Pai S, Nomeir A, Lim J, Lin CC, Affrime MB. Effect of felbamate on the pharmacokinetics of lamotrigine. J Clin Pharmacol. 1996;36:634–8.

    Article  CAS  Google Scholar 

  9. Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M, Rosenow F, Doty P, Hebert D, Sullivan T. Adjunctive lacosamide for partial onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia. 2009;50:443–53.

    Article  CAS  Google Scholar 

  10. Novy J, Patsalos PN, Sander JW, Sisodiya SM. Lacosamide neurotoxicity associated with concomitant use of sodium-blocking antiepileptic drugs: a pharmacodynamic interaction? Epilepsy Behav. 2011;20:20–3.

    Article  Google Scholar 

  11. Besag FM, Berry DJ, Pool F. Methsuximide lowers lamotrigine blood levels: a pharmacokinetic antiepileptic drug interaction. Epilepsia. 2000;41:624–7.

    Article  CAS  Google Scholar 

  12. May TW, Rambeck B, Jurgens U. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. Ther Drug Monit. 1996;18:523–31.

    Article  CAS  Google Scholar 

  13. Majid O, Laurenza A, Ferry J, Hussein Z. Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials. Br J Clin Pharmacol. 2016;82:422–30.

    Article  CAS  Google Scholar 

  14. Rivas N, Buelga DS, Elger CE, Santos-Borbujo J, Otero MJ, Dominguez-Gil A, Garcia MJ. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy. Ther Drug Monit. 2008;30:483–9.

    Article  CAS  Google Scholar 

  15. Zatreeh M, Tennison M, D’Cruz O, Beach RL. Anticonvulsant induced chorea: a role for pharmacodynamic drug interaction? Seizure. 2001;10:596–9.

    Article  Google Scholar 

  16. Bockbrader HN, Burger P, Knapp L. Pregabalin effect on steady state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. Epilepsia. 2011;52:405–9.

    CAS  PubMed  Google Scholar 

  17. Perucca E, Cloyd J, Critchley D, Fuseau E. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia. 2008;49:1123–41.

    Article  CAS  Google Scholar 

  18. Summary of product characteristics: Sulthiame (Ospolot). Phebra Pty, Ltd. Last update 21 Nov 2013.

    Google Scholar 

  19. Berry DJ, Besag FMC, Pool F, Natarajan J, Doose D. Lack of effect of topiramate on lamotrigine serum concentrations. Epilepsia. 2002;43:818–23.

    Article  CAS  Google Scholar 

  20. Stephen LJ, Sills GJ, Brodie MJ. Lamotrigine and topiramate may be a useful combination. Lancet. 1998;351:958–9.

    Article  CAS  Google Scholar 

  21. Kanner AM. When thinking of lamotrigine and valproic acid, think “pharmacokinetically”. Epilepsy Curr. 2004;4:206–7.

    Article  Google Scholar 

  22. Brodie MJ, Yuen AW. Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res. 1997;26:423–32.

    Article  CAS  Google Scholar 

  23. Reutens DC, Duncan JS, Patsalos PN. Disabling tremor after lamotrigine with sodium valproate. Lancet. 1993;342:185–6.

    Article  CAS  Google Scholar 

  24. Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia. 1999;40:1141–6.

    Article  CAS  Google Scholar 

  25. Mueller TH, Beeber AR. Delirium from valproic acid with lamotrigine. Am J Psychiatry. 2004;161:1128–9.

    Article  Google Scholar 

  26. Stolarek I, Blacklaw J, Forrest G, Brodie MJ. Vigabatrin and lamotrigine in refractory epilepsy. J Neurol Neurosurg Psychiatry. 1994;57:921–4.

    Article  CAS  Google Scholar 

  27. Levy RH, Ragueneau-Majlessi I, Brodie MJ, Smith DF, Shah J, Pan WJ. Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy. Ther Drug Monit. 2005;27:193–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK

    Philip N. Patsalos

Authors
  1. Philip N. Patsalos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip N. Patsalos .

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Patsalos, P.N. (2022). Lamotrigine. In: Antiseizure Medication Interactions. Springer, Cham. https://doi.org/10.1007/978-3-030-82790-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-82790-8_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-82789-2

  • Online ISBN: 978-3-030-82790-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation